China STEMI Care Project Phase 2

Study Overview
=================
Brief Summary
-----------------
The program is to improve STEMI medical care quality in China. With the documents issued by National Health and Family Planning Commission of the People's Republic of China, the program was initialed in at least 200 primary PCI capable hospitals together with hundreds of adjacent non-primary PCI capable hospitals in 15 provinces. STEMI patients with symptom onset within 30 days will be enrolled in 3 periods. In each period with 6-month interval, 30 patients will be enrolled consecutively from each PCI-capable center initially and from non-primary PCI capable hospitals later, thus at least 18,000 STEMI patients from primary PCI capable hospitals will be enrolled and all of them will be followed up for 1 year. Key performance indicators (KPIs) in STEMI care will be collected using both national PCI online registry and a program STEMI online registry database for the purpose of improvement of medical care. Hospital KPIs rank report and problem-based resolution will be feedback to each hospital after data analysis in each period. Comparison of every two cross-sectional data (self) and within one cross-sectional (inter-hospital) data will be used to evaluate the improvement of medical quality.

Official Title
-----------------
China STEMI Care Project Phase 2

Conditions
-----------------
ST-Elevation Myocardial Infarction

Intervention / Treatment
-----------------
* Other: clinical pathway


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: STEMI patients with symptom onset within 30 days Exclusion Criteria: None
Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| 1.STEMI patients with symptom onset within 30 days<br>First round enrollment of STEMI patients with symptom onset within 30 days | Other: clinical pathway<br> <br> |
| 2.STEMI patients with symptom onset within 30 days<br>Second round enrollment of STEMI patients with symptom onset within 30 days | Other: clinical pathway<br> <br> |
| 3.STEMI patients with symptom onset within 30 days<br>Third round enrollment of STEMI patients with symptom onset within 30 days | Other: clinical pathway<br> <br> |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Referfusion ratio in patients with symptom onset within 12 hours | Referfusion including primary PCI and thrombolysis is the key strategy in STEMI care | 12 hours | 
| Door-to-ballnoon time in patients with symptom onset within 12 hours | Door-to-ballnoon time is the key index to evaluate treatment of primary PCI | 12 hours | 
| Door-to-needle time in patients with symptom onset within 12 hours | Door-to-needle time is the key index to evaluate treatment of thrombolysis | 12 hours | 
| Hospital admission via ambulance ratio |  | 2 years | 
| Symptom onset to arrive in hospital |  | 2 years | 
| Bypass ED ratio in patients with symptom onset within 12 hours |  | 12 hours | 
| Usage of both DAPT, statin, β blocker and ACEI/ARB in patients without contraindication | DAPT means dual antiplatelet therapy | 3 yeras | 
| In-hospital morbidity |  | 2 yeras | 
| 1-year on time follow-up ratio |  | 1 year |